Literature DB >> 15343505

Stromal expression of vascular endothelial growth factor correlates with tumor grade and microvessel density in mammary phyllodes tumors: a multicenter study of 185 cases.

Gary M K Tse1, Philip C W Lui, C Soon Lee, Fred Y l Kung, Richard A Scolyer, Bonita K B Law, Tai-Shing Lau, Rooshdiya Karim, Thomas C Putti.   

Abstract

A retrospective review of 185 mammary phyllodes tumors (105 benign, 51 borderline, 29 malignant) from 4 centers was performed by immunohistochemistry to investigate the expression of vascular endothelial growth factor in the epithelial and stromal cells of mammary phyllodes tumors. The correlation of vascular endothelial growth factor with tumor grade, stromal cell nuclear pleomorphism, cellularity, mitotic rate, margin histomorphology, and the stromal microvessel density was evaluated. Vascular endothelial growth factor expression was found in the epithelium in 29% and in the stromal cells in 31% of cases. There was significant increase of vascular endothelial growth factor expression in the stromal cells with increasing degree of malignancy, but not the epithelium. Microvessel density in the stroma also showed significant correlation with tumor malignancy, and a correlation was shown with the stromal vascular endothelial growth factor expression. Statistical overlap of stromal vascular endothelial growth factor and microvessel density in predicting malignancy suggests that angiogenesis may be an effector mechanism for vascular endothelial growth factor. Assessment of stromal VEGF may be useful as an adjunctive diagnostic criterion in the histologic assessment of malignancy in phyllodes tumors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15343505     DOI: 10.1016/j.humpath.2004.01.023

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  17 in total

1.  Ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1 alpha from human mesenchymal stem cells.

Authors:  Eun Su Jeon; Soon Chul Heo; Il Hwan Lee; Yoon Ji Choi; Ji Hye Park; Kyung Un Choi; Do Youn Park; Dong Soo Suh; Man Soo Yoon; Jae Ho Kim
Journal:  Exp Mol Med       Date:  2010-04-30       Impact factor: 8.718

2.  Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer.

Authors:  Yelena Mironchik; Paul T Winnard; Farhad Vesuna; Yoshinori Kato; Flonne Wildes; Arvind P Pathak; Scott Kominsky; Dmitri Artemov; Zaver Bhujwalla; Paul Van Diest; Horst Burger; Carlotta Glackin; Venu Raman
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

3.  Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 in canine simple mammary gland adenocarcinomas.

Authors:  Ahmad N Al-Dissi; Deborah M Haines; Baljit Singh; Beverly A Kidney
Journal:  Can Vet J       Date:  2010-10       Impact factor: 1.008

4.  Endothelin-1 expression correlates with atypical histological features in mammary phyllodes tumours.

Authors:  Gary M Tse; Benjaporn Chaiwun; Kin-Mang Lau; Richard Scolyer; C Soon Lee; Rooshdiya Z Karim; Thomas C Putti; Bonita K Law; Philip C Lui; Puay Hoon Tan
Journal:  J Clin Pathol       Date:  2006-12-08       Impact factor: 3.411

5.  Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour.

Authors:  G M K Tse; F C Wong; A K H Tsang; C S Lee; P C W Lui; A W I Lo; B K B Law; R A Scolyer; R Z Karim; T C Putti
Journal:  J Clin Pathol       Date:  2005-06       Impact factor: 3.411

6.  Molecular pathogenesis of progression and recurrence in breast phyllodes tumors.

Authors:  Ana Richelia Jara-Lazaro; Puay Hoon Tan
Journal:  Am J Transl Res       Date:  2009-01-01       Impact factor: 4.060

7.  Expression of TWIST1, Snail, Slug, and NF-κB and methylation of the TWIST1 promoter in mammary phyllodes tumor.

Authors:  Sung-Im Do; Ji Yeon Kim; So Young Kang; Jae Joon Lee; Jeong Eon Lee; Seok Jin Nam; Eun Yoon Cho
Journal:  Tumour Biol       Date:  2012-11-14

8.  Borderline and malignant phyllodes tumors display similar promoter methylation profiles.

Authors:  Jo-Heon Kim; Yoo Duk Choi; Ji Shin Lee; Jae Hyuk Lee; Jong Hee Nam; Chan Choi; Min Ho Park; Jung Han Yoon
Journal:  Virchows Arch       Date:  2009-11-19       Impact factor: 4.064

9.  Evaluation of serum vascular endothelial growth factor (VEGF) and microvessel density (MVD) as prognostic indicators in carcinoma breast.

Authors:  S Shivakumar; B T Prabhakar; K Jayashree; M G R Rajan; Bharathi P Salimath
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-21       Impact factor: 4.553

10.  Apatinib treatment is effective for metastatic malignant phyllodes tumors of the breast: a case report.

Authors:  Xiaolu Wang; Li Xie; Wenjing Hu; Jing Yan; Xiaoping Qian; Lijing Zhu
Journal:  BMC Womens Health       Date:  2021-05-22       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.